Penserra Capital Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,920
Closed -$11K 1397
2021
Q3
$11K Buy
1,920
+15
+0.8% +$100 ﹤0.01% 1344
2021
Q2
$15K Buy
1,905
+5
+0.3% +$41 ﹤0.01% 1212
2021
Q1
$16K Sell
1,900
-40
-2% -$444 ﹤0.01% 991
2020
Q4
$23K Buy
1,940
+1,234
+175% +$17K ﹤0.01% 832
2020
Q3
$11K Buy
+706
New +$11.6K ﹤0.01% 804
2016
Q2
Sell
-4,833
Closed -$10.3K 988
2016
Q1
$10.3K Buy
4,833
+1,540
+47% +$8.04K 1% 33
2015
Q4
$21K Buy
+3,293
New +$21.6K ﹤0.01% 409

Other funds holding CGEN

Penserra Capital Management's CGEN Position: Q4 2021 in Review

Penserra Capital Management sold out of Compugen (CGEN) in Q4 2021, closing a stake of 1,920 shares — an estimated $11K sold.

Penserra Capital Management first reported a position in CGEN in Q4 2015 and held it in 7 quarters. The position peaked at $23K in Q4 2020. 114 funds tracked by Wall St. Rank hold CGEN as of Q4 2021.

  • Penserra Capital Management reported no remaining Compugen position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,920 Compugen shares in Q4 2021, an estimated $11K.
  • Penserra Capital Management first reported a position in Compugen in Q4 2015 and held it in 7 quarters.
  • Penserra Capital Management's Compugen position peaked at $23K in Q4 2020.
  • 114 funds tracked by Wall St. Rank held Compugen as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.